Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Clinical trial NCT05938036 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05938036
Sponsor: Aqualung Therapeutics Corp.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome (ARDS)

Start date: 2023-12-01
Primary completion: 2027-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.